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Abstract  41 
Title: A factor analysis approach to examining relationships among ovarian steroid  42 
concentrations, gonadotropin concentrations, and menstrual cycle length characteristics in  43 
healthy, cycling women.  44 
Study question: How are ovarian steroid concentrations, gonadotropins, and menstrual cycle  45 
characteristics inter-related within normal menstrual cycles?   46 
Summary answer: Within cycles, measures of estradiol production are highly related to one  47 
another, as are measures of progesterone production, however the two hormones also show some  48 
independence from one another, and measures of cycle length and gonadotropin concentrations  49 
show even greater independence, indicating minimal integration within cycles.  50 
What is known already: The menstrual cycle is typically conceptualized as a cohesive unit, with  51 
hormone levels, follicular development, and ovulation all closely inter-related within a single  52 
cycle. Empirical support for this idea is limited, however, and to our knowledge, no analysis has  53 
examined the relationships among all of these components simultaneously.   54 
Study design, size, duration: 206 healthy, cycling Norwegian women participated in a prospective  55 
cohort study (EBBA-I) over the duration of a single menstrual cycle. Of these, 192 contributed  56 
hormonal and cycle data used in the current analysis.    57 
Participants/materials, setting, methods: Subjects provided daily saliva samples throughout the  58 
menstrual cycle from which estradiol and progesterone concentrations were measured.  FSH and  59 
LH concentrations were measured in serum samples from three points in the same menstrual  60 
cycle and cycle length characteristics were calculated based on hormonal data and menstrual  61 
records. A factor analysis was conducted to examine the underlying relationships among 22  62 
variables derived from the hormonal data and menstrual cycle characteristics.   63 
Main results and the role of chance: Six rotated factors emerged, explaining 80% of the variance  64 
in the data. Of these, factors representing estradiol and progesterone concentrations accounted for  65 
37% and 13% of the variance, respectively. There was some association between measures of  66 3 
 
estradiol and progesterone production within cycles, however cycle length characteristics and  67 
gonadotropin concentrations showed little association with any measure of ovarian hormone  68 
concentrations.  69 
Limitations, reasons for caution: Our summary measures of ovarian hormones may be imprecise  70 
in women with extremely long or short cycles, which could affect the patterns emerging in the  71 
factor analysis.  Given that we only had data from one cycle on each woman, furthermore, we  72 
cannot how address cycle characteristics may covary within individual women across multiple  73 
cycles.  74 
Wider implications of the findings: Our findings are generalizable to other healthy populations  75 
with typical cycles, however may not be applicable to cycles that are anovulatory, extreme in  76 
length, or otherwise atypical. The results support previous findings that measures of estradiol  77 
production are highly correlated across the cycle, as are measures of progesterone production.  78 
Estradiol and progesterone concentrations are associated with one another, furthermore. However  79 
factor analysis also revealed more complex underlying patterns in the menstrual cycle,  80 
highlighting the fact that gonadotropin concentrations and cycle length characteristics are  81 
virtually independent of ovarian hormones. These results suggest that despite integration of  82 
follicular and luteal ovarian steroid production across the cycle, cycle quality is a multi-faceted  83 
construct, rather than a single dimension.   84 
Study funding/competing interest(s): The EBBA-I study was supported by a grant from the  85 
Norwegian Cancer Society (49 258, 05087); Foundation for the Norwegian Health and  86 
Rehabilitation Organizations (59010-2000/2001/2002); Aakre Foundation (5695–2000, 5754– 87 
2002), and Health Region East. The current analyses were completed under funding from the  88 
National Institutes of Health (K12 ES019852).  89 
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  92 
Introduction  93 
  94 
The menstrual cycle is typically characterized as a single, cohesive unit in which hormone levels,  95 
follicular development, and ovulation are all closely inter-related. From this perspective, high  96 
quality cycles are not only ovulatory, but have high estradiol and progesterone concentrations,  97 
characteristic mid-cycle LH and FSH peaks, and are approximately 28 days in length. At the  98 
other end of the spectrum, low quality cycles are not only anovulatory, but may have low  99 
estradiol and progesterone concentrations, lack discernible LH and FSH peaks, and be atypical in  100 
length.  In other words, the classical view of the menstrual cycle implies that the quality of a  101 
given cycle is consistent across multiple measures, including follicular development, ovarian  102 
steroid and gonadotropin concentrations, endometrial development, and cycle length  103 
characteristics. This concept of consistent quality across the cycle is often implicitly accepted,  104 
however few studies have directly examined this question. Certainly at the extreme end of the  105 
spectrum of impaired ovarian function, multiple aspects of hormone production and cycle  106 
characteristics can all be compromised, with possible cessation of menses and hormone cycling  107 
(Ellison, 1990). Within the range of typical, healthy cycling, however, the degree of cohesiveness  108 
or integration of cycle quality remains unclear. Empirically, if the quality of a cycle really is a  109 
single dimension, the various measureable components should show a high degree of covariance  110 
within cycles. The goal of the current analysis is to examine patterns of association among  111 
component parts of the menstrual cycle (estradiol concentrations, progesterone concentrations,  112 
gonadotropin concentrations, and cycle length variables) in order to better understand the normal  113 
menstrual cycle.  114 
  115 
Theoretical support for close correlation of estradiol and progesterone production comes from the  116 
fact that both ovarian steroids derive from the same underlying structures.  That is, the very cells  117 5 
 
that produce estradiol in the follicular phase- the theca and granulosa cells of the preovulatory  118 
follicle- are those that go on to comprise the progesterone-producing cells of the corpus luteum  119 
after ovulation (Strauss and Williams, 2004). Based purely on the underlying cellular physiology,  120 
therefore, we might predict consistency of ovarian steroid production across the menstrual cycle  121 
(e.g. robust follicular estradiol production associated with robust luteal estradiol and progesterone  122 
production). On the other hand, estrogen and progesterone play different physiological roles in  123 
reproduction, and epidemiological evidence indicates that they can vary independently of one  124 
another (Lipson and Ellison, 1996, Nunez-De La Mora, et al., 2008, Nunez-de la Mora, et al.,  125 
2007, Venners, et al., 2006).  For instance, one study measuring daily ovarian hormone profiles in  126 
premenopausal women found very low correlations between urinary estrogen and progesterone  127 
metabolite concentrations within a cycle (r=-0.003 to 0.13) (Windham, et al., 2002).  Thus,  128 
although a high degree of consistency between estradiol and progesterone indices might be  129 
expected, empirical support for that prediction is mixed.  130 
  131 
Much as we might expect consistency of ovarian steroid hormone production within a cycle, so  132 
might we predict that ovarian steroid production is closely associated with production of pituitary  133 
gonadotropins. Ovarian steroid hormone production and release comes from coordination of  134 
ovarian theca and granulosa cell activity and is dependent upon gonadotropin input from the  135 
pituitary gland, with luteinizing hormone (LH) stimulating theca cell function, while follicle  136 
stimulating hormone (FSH) influences estradiol production by the granulosa cells (Strauss and  137 
Williams, 2004). Although some follicular development can proceed in the absence of FSH  138 
stimulation suggesting there is limited ovarian hormone activity independent of pituitary input  139 
(Oktay, et al., 1998), gonadotropin stimulation is essential for advancing further to the steroid- 140 
producing antral phase (Irving-Rodgers, et al., 2001). The complex feedback interactions between  141 
gonadotropins and ovarian steroids continue throughout mid-cycle, when rising follicular  142 
estradiol levels drive preovulatory surges in FSH and LH (Richards, et al., 2002). The apparent  143 6 
 
interdependence of gonadotropin and ovarian steroid activity characteristic of normal ovarian  144 
function suggests that the two may be closely associated throughout the cycle, at least during  145 
certain periods. For instance, in one study of cycling women, there were weak correlations  146 
between estradiol and FSH early in the follicular phase, but higher (inverse) correlations in the  147 
mid-follicular phase (Robertson, et al., 2009) and other studies have found that estradiol has  148 
inhibitory effects on FSH secretion in the luteal phase (de Ziegler, et al., 1992, Lahlou, et al.,  149 
1999, Lasley, et al., 1975). In the luteal phase, moreover, both LH and FSH show weak to  150 
moderate negative correlations with progesterone concentrations, while LH and estradiol  151 
concentrations show a weak positive correlation (Robertson, et al., 2009).  Thus there is evidence  152 
to suggest some coordination of pituitary gonadotropin and ovarian steroid production within the  153 
cycle, although the strength and direction of the relationship may vary at different points in the  154 
cycle.    155 
  156 
That cycle length variables should be linked to hormone concentrations and follicular  157 
development is less obvious, but this prediction follows from the physiology nonetheless.  The  158 
length of the follicular phase reflects the speed at which the antral follicle is recruited and  159 
develops, and thus by extension, follicular phase length should be related to gonadotropin and  160 
ovarian steroid concentrations as well (Cabral and de Medeiros, 2007, Harlow, et al., 2000).  161 
Experimental evidence in primates suggests that if the antral follicle is destroyed, the  162 
characteristic preovulatory gonadotropin surge is delayed, extending both the length of follicular  163 
phase and that of the total cycle (Goodman, et al., 1977).  In humans, a limited body of work  164 
suggests associations between ovarian steroid concentrations and cycle length parameters,  165 
including total cycle length, follicular phase length, and luteal phase length, arguing further for  166 
consistency of cycle quality across multiple domains (Harlow, et al., 2000, Landgren, et al., 1980,  167 
Windham, et al., 2002). In particular, short follicular phases and short cycles may be associated  168 
with relatively high estrogen and progesterone concentrations, whereas longer follicular phases  169 7 
 
may be characterized by lower average estrogen concentrations (Harlow, et al., 2000, Landgren,  170 
et al., 1980). Other studies have also observed positive correlations between progesterone levels  171 
and luteal phase length (Landgren, et al., 1980, Windham, et al., 2002).   172 
  173 
To date, it has been difficult to study associations among different measures of ovarian function  174 
across the menstrual cycle because of the difficulty of obtaining repeated measures of hormonal  175 
variables across the entire cycle.  Only a handful of studies have measured complete, daily  176 
estradiol and progesterone profiles over the course of one or more cycles (De Souza, et al., 1998,  177 
Liu, et al., 2004, Matthews, et al., 2006, Santoro, et al., 2004, Windham, et al., 2002). The  178 
convenience and non-invasiveness of saliva collection compared to blood or urine makes it an  179 
ideal medium for measuring daily ovarian steroid profiles.  However the extremely low  180 
concentrations of estradiol in saliva made these analyses prohibitively difficult until relatively  181 
recently (O'Rourke and Ellison, 1993). In this analysis using data from healthy, cycling women  182 
participating in the Norwegian Energy Balance and Breast Cancer Aspects-I (EBBA-I) study, we  183 
adopt a factor analysis approach to examine whether the menstrual cycle truly is a cohesive unit.  184 
In particular, we focus on the relationships among four aspects of the menstrual cycle (estradiol  185 
concentrations, progesterone concentrations, gonadotropin concentrations, and measures of cycle  186 
length), looking at the strength of the associations between these components within cycles.  187 
  188 
Methods  189 
  190 
Subject population, participants, and study design  191 
Women were recruited for the EBBA-I study, based in Tromsø, Norway, between 2000 and 2002.   192 
The study’s goal was to examine the role of energetics and other lifestyle variables on known  193 
breast cancer risk factors in healthy, premenopausal women. To participate, women had to be age  194 
25-35 with regular menstrual cycles and could not have been pregnant, lactated, or used hormonal  195 8 
 
contraception in the previous six months. Women with known histories of infertility,  196 
gynecological disorders, and chronic illnesses (such as type II diabetes) were excluded as well.   197 
In total, 206 women participated in EBBA-I, and the subject population, recruitment methods,  198 
and study design have been described elsewhere in detail (Furberg, et al., 2005). Subjects  199 
received 1000 Norwegian kroner (approximately $160 US dollars at the time) to cover  200 
transportation and other expenses related to their participation.  201 
  202 
Ethical approval  203 
Participating women signed informed consent and the study was approved by the Regional  204 
Committee for Medical Research Ethics and the Norwegian Data Inspectorate as well as the  205 
human subjects review boards at all participating institutions.   206 
  207 
Salivary steroid assay  208 
As part of the study, subjects collected daily waking saliva samples over an entire menstrual  209 
cycle according to protocols developed by the Reproductive Ecology Laboratory at Harvard  210 
University (Lipson and Ellison, 1989).  Free estradiol concentrations were assayed in samples  211 
from 20 cycle days (reverse cycle days -5 to -24), and progesterone concentrations were assayed  212 
for the last 14 days of each cycle (reverse cycle days -1 to -14).  Levels of both hormones were  213 
measured using I-125-based radioimmunoassay (RIA) kits (Diagnostics Systems Laboratory,  214 
Webster, TX, USA) using methods reported elsewhere (Furberg, et al., 2005). The sensitivity of  215 
the estradiol assay was 4 pmol/L (1.1 pg/mL), the average intra-assay variability was 9%, and the  216 
interassay variability ranged from 23% to 13% for the low and high pools, respectively.  The  217 
sensitivity of the progesterone assay was 13 pmol/L (4.1 pg/mL). Based on our assayed samples,  218 
the average intra-assay variability was 10%, and the inter-assay variability ranged from 19% to  219 
12% for the low and high pools, respectively.    220 
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Once estradiol assays had been completed, the daily concentrations across each cycle were  222 
examined in order to identify the day of the greatest mid-cycle drop in estradiol using methods  223 
described elsewhere (Lipson and Ellison, 1996). For each cycle, a mid-cycle estradiol “drop day”  224 
was first determined. The drop day was defined as the second of the two consecutive days in a  225 
mid-cycle window during which the greatest decrease in estradiol occurred.  The mid-cycle  226 
window for identifying peak estradiol was days -18 to -12, thus the drop day was constrained to  227 
fall between days -17 to -11.  This estradiol drop provides a good marker for the timing of  228 
ovulation, and the drop day was subsequently designated as day ‘0’.  Thus days in the follicular  229 
phase have negative prefixes (e.g. day -1, day -2), whereas days in the luteal phase have positive  230 
prefixes (e.g. day +1, day +2). A drop day could not be assigned for 14 subjects. Eight of the 14  231 
had missing hormone data for at least one day during the interval between reverse cycle days -18  232 
to -12. The remaining six subjects had no discernable rise or drop in estradiol during the critical  233 
time window and their mid-cycle LH levels were low as well, suggesting that the cycles were  234 
anovulatory.  Because determination of drop day is needed to calculate hormonal indices and  235 
separate cycles into follicular and luteal phases, these 14 women were excluded and only the 192  236 
women with aligned cycles were included in analyses.   237 
  238 
Creation of ovarian hormone indices  239 
From the daily estradiol and progesterone concentrations we were able to calculate a number of  240 
different indices of hormone levels, representing different components or periods of ovarian  241 
function.  Each index was calculated as the mean hormone concentration across samples collected  242 
during a particular period of the cycle relative to ovulation (day 0). Seven estradiol indices were  243 
calculated for each cycle: total estradiol (mean estradiol for all cycle days measured) reflects  244 
average estradiol exposure across the cycle; follicular estradiol (mean estradiol, days -10 to -1)  245 
reflects average estradiol prior to ovulation; mid-follicular estradiol (mean estradiol, days -10 to - 246 
6) reflects estradiol production around the time of the emergence of the dominant follicle; late  247 10 
 
follicular estradiol (mean estradiol, days -5 to -1) reflects the secretory activity of the dominant  248 
follicle prior to ovulation;  maximum follicular estradiol (highest estradiol concentration  249 
measured between days -10 to -1), maximum estradiol (highest estradiol at any point in the  250 
cycle), and magnitude of the midcycle estradiol drop (maximum estradiol minus estradiol on day  251 
0) reflect midcycle estradiol secretion as well as the decrease in circulating estradiol  252 
accompanying ovulation of the dominant follicle. If follicular phase length was shorter than 10  253 
days, follicular estradiol and mid-follicular estradiol calculations were adjusted accordingly (e.g.  254 
if the follicular phase was only 9 days, was calculated as the mean of days -9 through -1, rather  255 
than -10 through -1).  Similarly, if data were missing (for instance, due to estradiol concentrations  256 
below the sensitivity limit at the beginning of the cycle), indices were calculated as the mean  257 
across the days with measurable concentrations in that interval.  258 
  259 
Six indices of progesterone concentrations were calculated as well. Total progesterone (mean  260 
progesterone, days 0 to +14) reflects average progesterone exposure during the luteal phase;  261 
early-mid luteal progesterone (mean progesterone, days 0 to +9) represents the average  262 
circulating progesterone concentrations during the beginning and middle of the luteal phase; mid- 263 
luteal progesterone (mean progesterone, days +5 to +9) reflects the level of progesterone  264 
secretion at the peak of the luteal phase; very early luteal progesterone (mean progesterone, days  265 
0 to +2) and early luteal progesterone (mean progesterone, days +3 to +5) together reflect the  266 
early luteal progesterone rise, before any possible effects of human chorionic gonadotropin (hCG)  267 
from a potential conceptus; and late luteal progesterone (mean progesterone, days +10 to +14)  268 
reflects post-peak secretion of progesterone during the regression of the corpus luteum prior to  269 
menstruation. If luteal phase length was shorter than 14 days, total progesterone and late luteal  270 
progesterone calculations were adjusted accordingly (e.g. if the luteal phase was 12 days, total  271 
progesterone was calculated as the mean of days 0 through +12, rather than 0  through +14).  272 
When progesterone values were missing for individual days, the hormone indices were calculated  273 11 
 
as the means of those days with data. Summary statistics for the hormonal variables are provided  274 
in Table 2.  275 
  276 
Calculation of menstrual cycle phase lengths   277 
Three cycle length variables were measured using the hormone data and self-reported dates of  278 
menses. Overall cycle length was the number of days from menstrual onset to menstrual onset, as  279 
determined by self-reported menses. Follicular phase length was the number of days from  280 
menstrual onset to the mid-cycle estradiol drop day. Finally, luteal phase length was the number  281 
of days from the day after the mid-cycle estradiol drop day to onset of subsequent self-reported  282 
menses.    283 
  284 
Serum sample collection and gonadotropin assay  285 
At three points in the cycle, fasting serum samples were taken by trained nurses at the University  286 
Hospital of Northern Norway, Tromsø. These collections were done between days 1-2, 7-12, and  287 
21, reflecting the early follicular, pre-ovulatory, and luteal phases of the cycle. Luteinizing  288 
hormone (LH) and follicular stimulating hormone (FSH) were measured in serum samples from  289 
all three time points using Techicon Immuno1 immunometric assays (Bayer Corp, Tarrytown,  290 
NY). Both assays were standardized against the WHO 2nd International Standard (for FSH: IRP  291 
78/549 and for LH: IRP 68/40). The sensitivity of the FSH assay was 0.1 IU/L and the coefficient  292 
of variation was less than 7 percent.  For LH, the assay sensitivity was 0.3 IU/L and the  293 
coefficient of variation was 5-10 percent.     294 
  295 
Statistical analyses  296 
All statistical analyses were carried out in SAS Enterprise 4.3 (SAS Corporation, Cary, NC).  297 
Because hormone values typically follow non-normal distributions, all hormone indices were first  298 
log transformed to normalize variances. We first examined bivariate correlations between the  299 12 
 
ovarian hormone indices in our analysis.  We then conducted a factor analysis by principal  300 
components extraction, with and without orthogonal varimax rotation of axes on the correlation  301 
matrix of the study variables. The goal of factor analysis is to condense a large number of  302 
correlated variables into a smaller number of factors and in doing so, reveal underlying  303 
relationships among the variables. Orthogonal varimax rotation then rotates these factors so that  304 
they are uncorrelated with one another, creating factors for which one or more variables have  305 
high loadings, while loadings for the other variables are close to zero (Manly, 2005). Each factor  306 
has an eigenvalue, which indicates the amount of variance in all of the variables that is accounted  307 
for by that factor, and following the conventionally used Kaiser criterion, only factors with  308 
eigenvalues greater than 1 (i.e. explaining more than 1 percent of the total variance) are retained  309 
in the analysis (Kaiser, 1958).  Thus factors with large eigenvalues explain a large amount of  310 
variance in the overall data, whereas factors with small eigenvalues explain little of the variance.  311 
A Scree plot (which helps to visually discriminate between those factors explaining a large  312 
fraction of the variance and those which are relatively unimportant) was made to confirm the  313 
number of factors that should be included in the analysis.  For each factor with an eigenvalue  314 
greater than 1, we examined the loading of each menstrual cycle variable, which is similar to a  315 
standardized regression coefficient when the factor is regressed on the variables (DeCoster,  316 
1998). Loadings of ≥0.7 were considered strong loadings, while those <0.7, but ≥0.35 were  317 
considered moderate loadings. Loadings <0.35 were considered weak to negligible.   318 
  319 
One of the useful aspects of principal component extraction is the collapsing of highly correlated  320 
variables into a smaller number of axes representing linear functions of those correlated variables.  321 
Here, for instance, although high correlations might be expected among the different indices of  322 
each steroid (particularly those that overlap), it is not necessarily the case that seemingly related  323 
indices would all cluster on the same rotated axes resulting from factor analysis.  Luteal and  324 
follicular estradiol secretion, for example, might be governed by different patterns of  325 13 
 
gonadotropin secretion and hence manifest significant independence.  Similarly mid-follicular  326 
estradiol might reflect the combined secretory activity of a recruited cohort of follicles under FSH  327 
stimulation, whereas late follicular and maximum follicular estradiol presumably reflect secretion  328 
by the dominant follicle alone. The degree to which these aspects of estradiol production are  329 
independent will affect the degree to which they individually correlate with average estradiol  330 
levels over the entire follicular phase or the entire cycle as well.  Thus the current analyses allow  331 
us to examine the relationships among the specified variables without making any a priori  332 
assumptions about the independence (or multicollinearity) of different indices of ovarian steroid  333 
levels and other cycle characteristics.  Instead, factor analysis allows us to identify those clusters  334 
of variables that are highly redundant and thus reduce the number of indices studied.   335 
  336 
Results  337 
  338 
General characteristics of the study subjects are provided in Table 1. The study population was  339 
predominantly Caucasian and highly educated with a mean age of 30 years. 61% of subjects were  340 
married and half had at least one child.  The average cycle length was 28 days (range: 20-47), of  341 
which 15 were spent in the follicular phase and 13 in the luteal phase. Bivariate analyses indicate  342 
moderate to strong positive correlations between the estradiol and progesterone indices and are  343 
presented in Table 2.  Most of the estradiol indices have correlation coefficients with each other  344 
in the range 0.7 to 0.95.  The exception is the magnitude of the midcycle estradiol drop, which  345 
correlates very weakly, and typically negatively, with the other estradiol variables.  Similarly, the  346 
progesterone indices have correlation coefficients with each other in the range of 0.57 to 0.97.   347 
Except for magnitude of the estradiol drop, the correlations between the estradiol and  348 
progesterone indices are moderate, ranging from 0.38 to 0.60.   349 
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The unrotated factor matrix (not shown) generated six factors with eigenvalues greater than 1.   351 
Typically, the first unrotated factor represents the single vector that captures the greatest amount  352 
of the multivariate variance and in this case, all of the estradiol and progesterone measures (aside  353 
from the magnitude of the estradiol drop) had loadings of 0.70 or greater on Factor 1.  Of the  354 
remaining variables, seven had loadings between 0.05 and 0.16, with the remaining three having  355 
loadings less than 0.05. Factor 1 of the unrotated matrix accounted for only 38% of the total  356 
multivariate variance in the sample, however, indicating that the majority of the multivariate  357 
variance could not be captured by a single axis.   358 
  359 
Subsequent orthogonal varimax rotation of the axes obtained from the factor analysis maximized  360 
the separation of the factor loadings of the original variables onto different axes and generated six  361 
rotated factors with eigenvalues greater than 1, which together explained 80 percent of the  362 
variation in the data.  Factor loadings for the six rotated factors are presented in Table 3. The  363 
varimax rotation largely succeeded in separating the original variables onto different axes, each of  364 
which was orthogonal to, or independent of, the others.   All variables loaded on at least one  365 
factor, but no variable had a strong loading (≥ 0.7) on more than one factor.  Two variables, mid- 366 
cycle LH and mid-cycle FSH, showed split moderate loadings on more than one factor.  Mid- 367 
cycle LH loaded strongly on Factor 5 and moderately (and negatively) on Factor 3, while mid- 368 
cycle FSH showed a moderate, negative loading on Factor 3, and moderate, positive loadings on  369 
Factors 4 and 5. Only two original variables, mid-cycle FSH and magnitude of the mid-cycle  370 
estradiol drop, did not have a strong loading on any of the six rotated factors.  Mid-cycle FSH  371 
instead had moderate loadings on three factors, while the magnitude of the mid-cycle estradiol  372 
drop had a moderate loading on one factor.    373 
  374 
The first rotated factor explained 37% of the variance and included all of the measures of  375 
estradiol except for the magnitude of the mid-cycle estradiol drop.  The second rotated factor  376 15 
 
included the six progesterone indices and explained 13% of the variance.  The third rotated factor  377 
accounted for 11% of the variance and included cycle length and follicular phase length with  378 
minor loadings on mid-cycle gonadotropin concentrations.  The fourth rotated factor explained  379 
9% of the variance and included luteal gonadotropin concentrations, with a minor loading on  380 
mid-cycle FSH concentrations and the magnitude of the estradiol drop. The fifth rotated factor,  381 
explaining 5% of the variance, had major loadings on early follicular and mid-cycle LH  382 
concentrations and minor loadings on early follicular and mid-cycle FSH loadings.  Finally, only  383 
luteal phase length was included in the sixth rotated factor, which accounted for 5% of the  384 
variance in the data set. Sensitivity analyses (not shown) using only subjects with complete daily  385 
hormone data did not change the basic relationships among variables and factors.  386 
  387 
Discussion  388 
  389 
The purpose of this analysis is to examine the extent to which the menstrual cycle is a cohesive  390 
unit in healthy, reproductive-age women, as measured by the strength of the relationships among  391 
hormonal measurements and cycle characteristics. Or, phrased as a question, to what extent is any  392 
one measure of menstrual function predictive of or independent of others within the same cycle?   393 
Of particular interest is the extent to which there is coordination of ovarian steroid production  394 
across the follicular and luteal phases of the cycle.  In our study population, the relationship  395 
between follicular phase estradiol and luteal phase progesterone is significantly positive, as  396 
reflected in the bivariate correlations. These correlations are much higher than reported in at least  397 
one other study in cycling women, in which correlations between urinary estradiol and  398 
progesterone metabolite concentrations were 0.13 or lower (Windham, et al., 2002).  Because  399 
urinary assays measure conjugated metabolite concentrations and are thus one or more steps  400 
removed from circulating free hormone concentrations, such assays may introduce additional  401 
noise related to inter-individual metabolic variation (Gann, et al., 2001). For that reason, the  402 16 
 
stronger correlations found in the current study based on free (bioactive) salivary steroid  403 
concentrations may be a more accurate reflection of the true relationship between estradiol and  404 
progesterone concentrations in healthy, cycling women.    405 
  406 
In the current study, the positive association between follicular and luteal steroid profiles is  407 
further illustrated by sorting the study subjects into quartiles on the basis of the indices of one  408 
steroid and comparing the full daily profiles of the other. Sorting the subjects into quartiles by  409 
mean follicular estradiol concentrations shows that women with high mean follicular estradiol  410 
concentrations also tend to have high progesterone concentrations throughout the luteal phase  411 
(Figure 1).  Similarly, when subjects are sorted by mean luteal progesterone concentrations, those  412 
with the highest quartile of luteal progesterone concentrations tend to have high follicular  413 
estradiol concentrations as well (Figure 2). In both cases, the quartiles are clearly distinct from  414 
one another. Thus crude analyses suggest that, across women, within a cycle, levels of one of  415 
these hormones are indicative of levels of the other.  416 
  417 
The subsequent factor analysis allowed simultaneous examination of the relationships between  418 
the ovarian steroid concentrations and other measures of cycle quality to identify more complex  419 
underlying patterns.  The factors obtained after varimax rotation represent the “sorting” of  420 
variables into groups that are highly correlated among the group while being orthogonal, or  421 
independent, of the groups represented by other factors. Factor 1 has very strong loadings (0.85 or  422 
greater) for all the estradiol indices except the magnitude of the estradiol drop.  It reflects the high  423 
consistency of estradiol production across the ovarian cycle and supports previous work finding  424 
high correlations between estradiol measures at multiple points across the cycle (Windham, et al.,  425 
2002).  The progesterone indices load weakly on this factor (0.20 to 0.30), with loadings being  426 
highest for early luteal progesterone measures and lower for indices capturing the later part of the  427 
luteal phase. This suggests that estradiol and progesterone production cannot be fully  428 17 
 
disentangled, particularly in the early luteal phase. Factor 2 has very high loadings (0.73 or  429 
greater) for all the progesterone indices, suggesting that progesterone production is highly  430 
consistent across the luteal phase. In Factor 2 there are weak loadings (0.2 to 0.34) for most of the  431 
estradiol indices, again indicating that there is some aspect of the relationship between  432 
progesterone and estradiol production that cannot be disarticulated, as suggested in the crude  433 
analyses.  434 
  435 
Nevertheless, the degree to which indices of the two ovarian steroids separate onto different axes  436 
in the factor analysis reflects the degree to which they are actually independent of each other. It is  437 
noteworthy, that no other variables have loadings on the first two rotated factors, which we  438 
therefore regard as the estradiol and progesterone factors, respectively.  In particular, the loadings  439 
for both the gonadotropin variables and the cycle length measures are extremely low. This  440 
suggests that a woman’s circulating estradiol and progesterone concentrations are not a clear  441 
function of her circulating gonadotropin concentrations, nor are they closely related to her cycle  442 
length. Rather, other factors including gonadotropin receptor densities or sub-types, co- 443 
gonadotropins such as insulin and IGF-1, or other unknown genetic, developmental, or  444 
constitutional components may explain inter-individual variance in ovarian steroid  445 
concentrations.  It remains possible that differences in gonadotropin concentrations may account  446 
for more of the documented within-individual variance in ovarian steroid concentrations (between  447 
multiple cycles in the same woman, for instance) (Lipson and Ellison, 1996, Venners, et al.,  448 
2006).  449 
  450 
Factor 3 has very high loadings (0.88 or greater) for total cycle length and follicular phase length,  451 
which confirms the close association between follicular phase length and overall cycle length that  452 
has been noted elsewhere (Fehring, et al., 2006, Waller, et al., 1998).  The moderate negative  453 
loadings of the mid-cycle concentrations of LH and FSH on this factor are more surprising,  454 18 
 
suggesting that factors associated with slow follicular growth (resulting in a longer follicular  455 
phase and longer total cycle length) may later result in poor steroid response in the luteal phase.   456 
Because this factor is independent of steroid concentrations themselves (Factors 1 & 2), even in  457 
the luteal phase, it may indicate that higher gonadotropin levels are required to stimulate a given  458 
amount of steroid production in cycles with longer follicular phases than in those with shorter  459 
follicular phases.  This may again be consistent with variation in the ovarian responsiveness to  460 
gonadotropin stimulation rather than the level of that stimulation itself, an effect that might be  461 
moderated at the receptor level. Further study is needed to understand these unexpected  462 
relationships.  463 
  464 
Factor 4 has strong loadings (0.80 or greater) for luteal FSH and LH concentrations. It also has  465 
moderate loadings for mid-cycle FSH (0.49) and the magnitude of the mid-cycle estradiol drop  466 
(0.41) It is noteworthy that the magnitude of the mid-cycle estradiol drop only clusters with luteal  467 
gonadotropins (albeit moderately) and not with any of the ovarian steroid measures. In fact,  468 
magnitude of the mid-cycle estradiol drop is the only steroid index that correlates significantly  469 
with levels of gonadotropin stimulation, although it is somewhat surprising that it clusters with  470 
luteal, rather than mid-cycle gonadotropin concentrations.   Baseline gonadotropin concentrations  471 
tend to be very low across the entire luteal phase and pulsatile release of gonadotropins occurs at  472 
low frequency (Hall, 2004, Johnson and Everitt, 2000), so it is unclear why they should be  473 
associated with the magnitude of the estradiol drop. Additional research is needed to confirm and  474 
better understand this unexpected observation.   475 
  476 
Factor 5 has high loadings (greater than 0.70) for early follicular and mid-cycle LH, with  477 
moderate loadings (0.5-0.7) for early follicular and mid-cycle FSH. This indicates that  478 
gonadotropin concentrations in the first half of the cycle are closely associated even though the  479 
two have distinct functional differences, with FSH stimulating further development of the antral  480 19 
 
follicle while LH promotes ovarian steroid production and eventually, ovulation (Hall, 2004,  481 
Strauss and Williams, 2004). Nevertheless, given that both are produced and secreted by a  482 
common source (the pituitary gland) and that both are responsive to fluctuating ovarian steroid  483 
concentrations (through negative feedback), it is not surprising that FSH and LH concentrations  484 
would load on the same factor. More surprising, perhaps, is how weak the ovarian steroid  485 
loadings are on this factor, which may indicate that across women, there is little relationship  486 
between early follicular and mid-cycle gonadotropins and ovarian steroid concentrations.  Once  487 
again, this suggests that it may be sensitivity to gonadotropin stimulation (for instance through  488 
receptor densities or the effect of co-gonadotropins), and not absolute gonadotropin  489 
concentrations that are most important for regulating ovarian steroid production.   490 
  491 
Finally, only luteal phase length loads on Factor 6 (0.97), indicating that it is virtually  492 
independent of the other hormone and cycle characteristics considered in this analysis.  It is not  493 
surprising that luteal phase length did not cluster with the other cycle length variables given that  494 
the literature suggests that while total cycle length and follicular phase length are tightly  495 
correlated, luteal phase length tends to be less variable and show only moderate correlations with  496 
both (Fehring, et al., 2006, Waller, et al., 1998).  In fact, one study found that only three percent  497 
of the variance in total cycle length was attributable to variation in luteal phase length, whereas  498 
follicular phase variation explained over 84 percent (Waller, et al., 1998).  At least one study has  499 
identified differences in urinary ovarian steroid concentrations in relation to luteal phase length,  500 
however those differences were in comparisons of cycles with short (≤10 days), average (11-14  501 
days), and long (≥15 days) luteal phases and did not consider luteal phase lengths continuously  502 
within the normal range (Windham, et al., 2002). In general, little is known about predictors or  503 
determinants of luteal phase length and additional research is needed to understand the existing  504 
variation and how it is related to other cycle indicators of ovarian function.  505 
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Overall, the results of this factor analysis suggest that although there is some consistency of  507 
menstrual function across domains, the particular cycle measures considered here also show  508 
considerable independence from one another across women. Perhaps of greatest interest are the  509 
associations between estradiol and progesterone indices, which clustered onto two distinct  510 
factors, but also showed minor loadings on each other’s primary factors, suggesting some inter- 511 
dependence between the two. This finding is interesting in light of previous work suggesting that  512 
follicular estradiol concentrations are higher in conception cycles than non-conception cycles  513 
(Lipson and Ellison, 1996). One explanation is that high estradiol concentrations better stimulate  514 
the developing oocyte and prime the endometrium for proliferation, thus increasing the odds of a  515 
successful conception. Our results suggest a second explanation should be considered as well,  516 
namely that there may also be correlated luteal phase effects, including endometrial secretions  517 
and support for implantation that is necessary for successful conception. The associations  518 
between estradiol measures (which are primarily follicular) and progesterone measures (which  519 
are luteal)  is clinically important, moreover, in that it further supports the idea that luteal phase  520 
defects are actually product of problems with follicular development earlier in the cycle  521 
(DiZerega and Hodgen, 1981).   522 
  523 
At the same time, estradiol and progesterone measures also showed a degree of independence  524 
from one another, and the fact that ovarian steroid concentrations were not associated with  525 
variation in gonadotropin concentrations or in cycle and phase lengths, moreover, suggests that it  526 
may be mediated by tissue sensitivity, perhaps reflecting differences in receptor expression or  527 
variation, or other physiological, genetic, developmental, or constitutional factors.  Such a  528 
mechanism would be consistent with findings of a study of adult Bangladeshi migrants to the UK,  529 
that indicated that progesterone, but not estradiol, was related to individual developmental history  530 
(Nunez-De La Mora, et al., 2008, Nunez-de la Mora, et al., 2007). Indeed, at least one study  531 
found that progesterone levels tend to be predictable within individuals over intervals of as much  532 21 
 
as one year, whereas estradiol levels may vary dramatically within individuals over the same time  533 
period (Chatterton, et al., 2005). The dissociation of estradiol and progesterone profiles observed  534 
in such studies suggests that developmental history may exert long-lasting influence on some  535 
aspects of ovarian steroid production, whereas other aspects are more responsive to acute cues in  536 
the immediate environment.    537 
  538 
There are some limitations to the interpretation of results from this study. First, the current study  539 
assessed only inter-individual effects, finding, for instance, that women who have high estradiol  540 
levels tend to have high progesterone levels and vice versa.  Because hormone levels were only  541 
measured for the duration of a single cycle in this study, we are unable to examine whether the  542 
same trend holds between cycles within individual women. Additional research following women  543 
longitudinally over time is needed to determine whether, within a given woman, high estradiol  544 
cycles are likely to also feature high progesterone levels, while low estradiol cycles tend to have  545 
low progesterone levels. Similarly, our results do not address whether other cycle characteristics  546 
tend to covary within individual women across multiple cycles.   547 
  548 
Because we measured estradiol concentrations only in samples collected on reverse cycle days -5  549 
to -24 (i.e. from 5 to 24 days before the start of the next menstrual bleeding), our estradiol indices  550 
may be inaccurate for any women with extremely long cycles.  Although the recruitment criteria  551 
generally excluded women with atypical cycles, in practice, approximately 5 percent of subjects  552 
had cycles longer than 35 days.  In a 35 day cycle, for instance, by assaying estradiol  553 
concentrations only in days -5 to -24 of the cycle, our calculated estradiol indices are artificially  554 
truncated, omitting concentrations in the early follicular phase. By contrast, in women with  555 
shorter cycles, nearly the entire follicular phase would be captured in our estradiol indices.  556 
Similarly, given that progesterone concentrations were only assayed in sample from reverse cycle  557 
days -1 to -14 (i.e. from 1 to 14 days before the start of the next menstrual bleeding), in women  558 22 
 
with extremely long luteal phases, the progesterone indices might not capture the earliest days of  559 
the luteal phase. For several reasons, however, we believe that this potential error is unlikely to  560 
affect our results.  First, we conducted a sensitivity analysis (not shown) restricting the analyses  561 
to subjects with cycle lengths ranging from 24-34 days and found that although there were slight  562 
differences in the exact factor loadings, the patterns and relationships that emerged were  563 
unchanged from those found using the whole cohort. Second, the fact that ovarian hormones and  564 
cycle phase lengths load on different factors in our analysis suggests the two are largely  565 
independent of one another. If there were significant confounding of these variables, there would  566 
have been strong loadings of ovarian hormone and cycle length characteristics on the same  567 
factors, which there was not. Ultimately, if there were bias due to improper calculation of  568 
hormone indices in long cycles, it would be for cycles with longer follicular phases to have higher  569 
average estradiol levels (since it would be the early follicular levels, which are typically low, that  570 
were omitted from the calculated indices), and we do not see any evidence of that.  Any bias in  571 
progesterone levels due to cycle length would be similar, but there is strong evidence from many  572 
studies, including these data, that variation in luteal phase length is minimal (Matsumoto, et al.,  573 
1962, Vollman, 1977).  Thus we suggest that any bias in this regard is negligible.   574 
  575 
Another limitation is our subject population, which was specifically recruited to be ages 25-35  576 
and self-identifying as having regular cycles.  Our population’s cycle length and cycle phase  577 
lengths were typical of healthy women in this age range, however we cannot necessarily  578 
extrapolate our findings to address this question in other groups of women (Chiazze, et al., 1968,  579 
Treloar, et al., 1967, Vollman, 1977).  In particular, women with less typical cycles (who would  580 
have been excluded from participation in the current study) might show different patterns of cycle  581 
hormones and characteristics, as might the 14 subjects whose hormonal profiles did not allow us  582 
to readily identify an estradiol drop day (and hence were excluded from analysis). Whether these  583 
results also apply to younger and older women (whose cycles may tend to be more erratic and  584 23 
 
have lower hormone levels) remains unknown (Chiazze, et al., 1968, Lipson and Ellison, 1992,  585 
Treloar, et al., 1967).  Further research is also needed to determine whether these patterns hold  586 
true in non-Western populations in which the level of ovarian function (as evidenced by estradiol  587 
and progesterone concentrations) is typically lower (Ellison, et al., 1993).  Given the results of  588 
migrant studies (Nunez-De La Mora, et al., 2008, Nunez-de la Mora, et al., 2007), it may be of  589 
particular interest to examine women whose current environment differs radically from the  590 
environment in which they were born and raised.  Perhaps under such conditions, there will be  591 
even weaker relationships across domains, with different cycle components reflecting  592 
developmental and current conditions.   593 
  594 
Finally, our findings on the relative independence of gonadotropin concentrations from other  595 
measures of cycle quality should be interpreted with caution.  As discussed, one possibility is that  596 
although serum gonadotropin concentrations may not be directly associated with ovarian steroid  597 
concentrations or cycle length characteristics, other indicators of gonadotropin activity (such as  598 
ovarian receptor densities) may be.  It is also possible, however, that because gonadotropins are  599 
released in approximately hourly pulses (Kazer, et al., 1987, Moret, et al., 2009), our  600 
measurement techniques (based on single serum samples at three points in the cycle) may have  601 
been too imprecise to capture circulating concentrations and have resulted in additional “noise” in  602 
our data.  Gonadotropin concentrations would be better quantified by repeated blood sampling at  603 
short intervals (approximately five minutes) during an extended time period followed by pulse  604 
detection analysis (Moret, et al., 2009). Even with that improved methodology, however, we  605 
would not be able to address whether the serum gonadotropin concentrations reflected the  606 
concentrations in the follicle, which are ultimately of greatest relevance and interest.   607 
  608 
In conclusion, this study is the first to directly address the extent to which multiple components of  609 
the menstrual cycle and ovarian function are inter-related in healthy, cycling, Western women.  610 24 
 
We have found that there is a significant degree of coordination of ovarian steroid production  611 
across the cycle, however estradiol and progesterone production also show considerable  612 
independence from one another. We have determined, furthermore, that across women,  613 
circulating gonadotropin concentrations and cycle length characteristics are almost entirely  614 
unrelated to ovarian steroid concentrations, suggesting that these aspects of cycle quality are  615 
independent of one another. Contrary to the textbook depiction of the menstrual cycle, cycle  616 
quality is not uniform across measures. Even in healthy, cycling women, different components of  617 
the cycle (ovarian steroids, gonadotropins, and cycle phase lengths) do not necessarily covary in a  618 
straight-forward, predictable manner.  Future research may look at not only how these measures  619 
of ovarian function are related to (or independent of) one another within women, but also how  620 
additional aspects of ovarian function, such as follicular development, follicular gonadotropin  621 
levels, or endometrial proliferation fit into this complex system.   622 
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